InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2023-07-10 | Daniel Goldman(D-NY10) | house | Sale | $1,001 - $15,000 |
| 2023-03-31 | Daniel Goldman(D-NY10) | house | Sale | $1,001 - $15,000 |
| 2023-02-27 | Daniel Goldman(D-NY10) | house | Purchase | $1,001 - $15,000 |
No financial data available for OTSKY.
Company may not file with SEC or CIK is unresolved.
Otsuka Holdings Co., Ltd. 2026 Q1 - Results - Earnings Call Presentation
FDA Fast-Tracks Review of Some Psychedelic Drugs. This Stock Is Set to Benefit.
Otsuka Holdings Co., Ltd. (OTSKY) M&A Call Prepared Remarks Transcript
Otsuka Holdings Co., Ltd. (OTSKY) Otsuka Holdings Co., Ltd., - M&A Call - Slideshow
J&J hits main goal in early-stage trial for drug delivery system
Otsuka Holdings Co., Ltd. 2025 Q4 - Results - Earnings Call Presentation
Otsuka Holdings Co., Ltd. (OTSKY) Q4 2025 Earnings Call Prepared Remarks Transcript
Assessing Whether Otsuka Holdings (TSE:4578) Is Overvalued After Recent Share Price Momentum
Recent Price Trend in Otsuka Holdings Co., Ltd. - Unsponsored ADR (OTSKY) is Your Friend, Here's Why
Ionis, Otsuka win EU nod for hereditary angioedema therapy
Underactive Bladder Syndrome Market to Observe Stunning Growth at a CAGR of 22.1% During the Forecast Period (2025-2034) | DelveInsight
Otsuka Holdings Co., Ltd. - Unsponsored ADR (OTSKY) Is a Great Choice for 'Trend' Investors, Here's Why